Baltimore, Maryland
United States
13
2026-06-11
6
2025-11-25
These are the the leading inventors for applications assigned to Elixirgen Therapeutics, Inc.:
Elixirgen Therapeutics, Inc. based in Baltimore, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#2 | 2025-10-30ANTIGENS FOR CANCER IMMUNOTHERAPY
#3 | 2025-05-01CELL THERAPY PROTOCOL SYSTEMS AND METHODS
#4 | 2025-01-23TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES
#5 | 2024-10-24TEMPERATURE-CONTROLLABLE, RNA IMMUNOTHERAPEUTIC FOR CANCER
#6 | 2024-08-15TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES
#7 | 2023-07-20 ✅ Patent 12,478,659 granted on 2025-11-25METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#8 | 2022-11-24 ✅ Patent 12,060,568 granted on 2024-08-13Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#9 | 2022-10-20 ✅ Patent 12,478,657 granted on 2025-11-25METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#10 | 2021-12-09 ✅ Patent 11,421,248 granted on 2022-08-23Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#11 | 2019-09-19METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#12 | 2019-09-19 ✅ Patent 11,389,504 granted on 2022-07-19Methods of using ZSCAN4 for rejuvenating human cells
#13 | 2014-10-30 ✅ Patent 10,744,183 granted on 2020-08-18Methods of using ZSCAN4 for rejuvenating human cells
Also check out Elixirgen Therapeutics, Inc.'s (Baltimore, United States) applicant profile with 12 patent applications submitted.
170138 ⎘